ALLIQUA BIOMEDICAL INC's ticker is ALQA and the CUSIP is 019621309. A total of 18 filers reported holding ALLIQUA BIOMEDICAL INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $701,000 | +91.0% | 238,428 | +21.4% | 0.00% | – |
| Q4 2018 | $367,000 | +8.9% | 196,430 | +32.4% | 0.00% | – |
| Q3 2018 | $337,000 | -34.9% | 148,380 | -42.8% | 0.00% | – |
| Q2 2018 | $518,000 | +117.6% | 259,260 | +111.5% | 0.00% | – |
| Q1 2018 | $238,000 | +12.8% | 122,580 | +5.1% | 0.00% | – |
| Q4 2017 | $211,000 | – | 116,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tekla Capital Management LLC | 148,500 | $437,000 | 0.02% |
| Omnia Family Wealth, LLC | 1,689 | $5,000 | 0.00% |
| Renaissance Technologies | 238,428 | $701,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 20,500 | $60,000 | 0.00% |
| Private Advisor Group, LLC | 12,185 | $36,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 11 | $0 | 0.00% |
| UBS Group AG | 4,564 | $13,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 17,352 | $51,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |